CD4 and neoplasm: Because CD8+ T cells are generally thought to be primarily activated by cDC1s 17-19, while CD4+ T cells require cDC2s for initial priming 17, defining both the activation and relative acquisition of tumor antigen by each DC subset may help identify opportunities for therapeutically tuning the relative contributions of effector and helper T cells to the BH-induced anti-tumor immunity.